Editor - Lynn C. Yeoman | Baylor College of Medicine | 18337
ISSN: 2476-2067

Toxicology: Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Lynn C. Yeoman

Lynn C. Yeoman
Lynn C. Yeoman
Medicine and Allied Health Sciences,
Baylor College of Medicine,
Baylor College of Medicine


Dr. Lynn C. Yeoman is currently Professor of Pharmacology, Medicine and Allied Health Sciences at Baylor College of Medicine in Houston, Texas. As Director of the Medical Pharmacology Course he is responsible for all pharmacology taught to medical students. In addition, he lectures on various aspects of pharmacology, i.e., autonomic pharmacology, drug metabolism, pharmacogenomics, drug approval and receptor characterization to medical students, graduate students, allied health students and residents. He holds the following administrative positions: Director of the Education Resource Center, Director of the Office of Undergraduate Medical Education and Texas Medical Center Library Student Services Liaison. Dr. Yeoman holds a United States patent for a monoclonal antibody-based test for the detection of a colon cancer marker in human serum. He served as Associate Director of Cell and Molecular Biology in the Oncology Drug Discovery Program at Bristol-Myers Squibb Co. in Wallingford, Connecticut. Dr. Yeoman is currently Director of the College’s Problem-based Learning Program. He is Baylor College of Medicine’s Member of the United States Pharmacopeia’s Council of the Convention and serves on several USP Expert Panels for the General Chapters Biological Assays Expert Committee.

Research Interest

Cancer Biology: Antisense DNA Therapeutics; Autocrine Growth Factor Regulation; Monoclonal Antibody Drugs; Nuclear Protein Characterization; Oncology Drug Discovery



Global Speakers in the subject

Global Experts in the subject